Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics

OBJECTIVE: Second-generation antipsychotics (SGAs) have a high risk of causing metabolic syndrome (MetS). There is accumulating evidence supporting the fact that the activation of inflammatory pathway contributes to the development of MetS and further aggravates cognitive impairment. This study aime...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuropsychiatr Dis Treat
Huvudupphovsmän: Fang, Xinyu, Wang, Yewei, Chen, Yan, Ren, Juanjuan, Zhang, Chen
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove 2019
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6681158/
https://ncbi.nlm.nih.gov/pubmed/31534339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S202159
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk